SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001628280-22-022758
Filing Date
2022-08-12
Accepted
2022-08-12 21:10:51
Documents
2
Period of Report
2022-08-09

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_166035303590377.html 3  
1 FORM 3 wf-form3_166035303590377.xml 3 1690
2 POWER OF ATTORNEY, EXHIBIT 24.1 HAMED SHAHBAZI chromadex-formsection16pow.htm EX-24 3218
  Complete submission text file 0001628280-22-022758.txt   6409
Mailing Address 10900 WILSHIRE BLVD SUITE 600 LOS ANGELES CA 90024
Business Address 10900 WILSHIRE BLVD SUITE 600 LOS ANGELES CA 90024 310-388-6706
ChromaDex Corp. (Issuer) CIK: 0001386570 (see all company filings)

IRS No.: 262940963 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2833 Medicinal Chemicals & Botanical Products

Mailing Address C/O CHROMADEX, INC. 1735 FLIGHT WAY, SUITE 200 TUSTIN CA 92782
Business Address
Shahbazi Hamed (Reporting) CIK: 0001942711 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37752 | Film No.: 221162002